These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 9676345)
1. [The effect of pretreatment with ranitidine on the pharmacokinetics and gastrointestinal transit of a sustained-release theophylline preparation]. Wilson CG; Washington N; Greaves JL; Blackshaw PE; Perkins AC; Barkworth MF; Rehm KD Arzneimittelforschung; 1998 May; 48(5A):561-8. PubMed ID: 9676345 [TBL] [Abstract][Full Text] [Related]
2. Effect of pretreatment with ranitidine on the pharmacokinetics and gastrointestinal transit of a sustained release theophylline preparation. Wilson CG; Washington N; Greaves JL; Blackshaw PE; Perkins AC; Barkworth MF; Rehm KD Arzneimittelforschung; 1991 Nov; 41(11):1154-9. PubMed ID: 1810260 [TBL] [Abstract][Full Text] [Related]
3. Effect of food and ranitidine on saquinavir pharmacokinetics and gastric pH in healthy volunteers. Kakuda TN; Falcon RW Pharmacotherapy; 2006 Aug; 26(8):1060-8. PubMed ID: 16863482 [TBL] [Abstract][Full Text] [Related]
4. Influence of gastric pH changes on pharmacokinetic of a sustained-release formulation of theophylline. Ferrari M; Olivieri M; Romito D; Biasin C; Barozzi E; Bassetti S Riv Eur Sci Med Farmacol; 1991; 13(5-6):269-74. PubMed ID: 1819857 [TBL] [Abstract][Full Text] [Related]
5. H2-antagonist derangement of the kinetics of sustained-release oral theophylline. Dal Negro R; Turco P; Zoccatelli O; Trevisan F; Pomart C Int J Clin Pharmacol Ther Toxicol; 1985 Jun; 23(6):329-32. PubMed ID: 2862112 [TBL] [Abstract][Full Text] [Related]
6. [Pharmacokinetics of theophylline in sustained-release formulation in young asthmatics]. Witschital K; Fuchs WS; Heese U; von Nieciecki A; Laicher A Arzneimittelforschung; 1998 May; 48(5A):593-6. PubMed ID: 9676351 [TBL] [Abstract][Full Text] [Related]
7. [Requirements for product quality of theophylline sustained-release preparations]. Fuchs WS; Hens C; von Nieciecki A Arzneimittelforschung; 1998 May; 48(5A):556-61. PubMed ID: 9676344 [TBL] [Abstract][Full Text] [Related]
8. Tolerance during 8 days of high-dose H2-blockade: placebo-controlled studies of 24-hour acidity and gastrin. Smith JT; Gavey C; Nwokolo CU; Pounder RE Aliment Pharmacol Ther; 1990; 4 Suppl 1():47-63. PubMed ID: 1983346 [TBL] [Abstract][Full Text] [Related]
9. Effects of cimetidine and ranitidine on the pharmacokinetics of a chronotherapeutically formulated once-daily theophylline preparation (Uniphyl). Fraser IM; Buttoo KM; Walker SE; Stewart JH; Babul N Clin Ther; 1993; 15(2):383-93. PubMed ID: 8519046 [TBL] [Abstract][Full Text] [Related]
10. The effect of raising gastric pH with ranitidine on the absorption and elimination of theophylline from a sustained-release theophylline tablet. Betlach CJ; Straughn AB; Meyer MC; Bialer M; Vashi VI; Liebermann P; González MA Pharm Res; 1991 Dec; 8(12):1516-9. PubMed ID: 1808616 [TBL] [Abstract][Full Text] [Related]
11. [Pharmacokinetics of a new fluid theophylline sustained-release drug form. Microcapsules in a sachet]. Fuchs WS; Weiss G; von Nieciecki A; Laicher A; Gay S; Pabst G; Müller M Arzneimittelforschung; 1998 May; 48(5A):612-7. PubMed ID: 9676354 [TBL] [Abstract][Full Text] [Related]
12. Twenty-four-hour intragastric pH: tolerance within 5 days of continuous ranitidine administration. Lachman L; Howden CW Am J Gastroenterol; 2000 Jan; 95(1):57-61. PubMed ID: 10638559 [TBL] [Abstract][Full Text] [Related]
13. [Absorption profile and absolute bioavailability of a theophylline sustained-release preparation]. Pabst G; Weber W; Barkworth MF; Müller M; Rehm KD Arzneimittelforschung; 1998 May; 48(5A):574-9. PubMed ID: 9676347 [TBL] [Abstract][Full Text] [Related]
14. [Pharmacokinetics of a theophylline sustained-release formulation after single and twice daily dosage]. Fuchs WS; von Nieciecki A; Pabst G; Müller M; Dilger C; Gay S; Laicher A; Stanislaus F Arzneimittelforschung; 1998 May; 48(5A):589-92. PubMed ID: 9676350 [TBL] [Abstract][Full Text] [Related]
15. [In vivo verification of in vitro release specifications of a theophylline sustained-release preparation]. von Nieciecki A; Fuchs WS; Pabst G; Müller M; Dilger C; Gay S; Laicher A; Stanislaus F Arzneimittelforschung; 1998 May; 48(5A):580-3. PubMed ID: 9676348 [TBL] [Abstract][Full Text] [Related]
16. Comparison of the effects of ranitidine effervescent tablets and magnesium hydroxide-aluminium oxide on intragastric acidity. A single-centre, randomised, open cross-over study. Propst A; Propst T; Judmaier G Arzneimittelforschung; 1996 Jun; 46(6):621-4. PubMed ID: 8767354 [TBL] [Abstract][Full Text] [Related]
17. Reduction of postprandial gastric acidity and pepsin concentration by ranitidine and antacids in healthy volunteers. Berstad A; Rydning A; Kolstad B; Frislid K Scand J Gastroenterol Suppl; 1981 Jun; 69():67-73. PubMed ID: 6119785 [TBL] [Abstract][Full Text] [Related]
18. [The effect of food on theophylline absorption]. Pabst G; Weber W; Müller M; Barkworth MF Arzneimittelforschung; 1998 May; 48(5A):569-73. PubMed ID: 9676346 [TBL] [Abstract][Full Text] [Related]
19. Lack of effect of ranitidine on gastric luminal pH and mucosal PCO2 during the first day in the ICU. Jakob SM; Parviainen I; Ruokonen E; Uusaro A; Takala J Acta Anaesthesiol Scand; 2005 Mar; 49(3):390-6. PubMed ID: 15752407 [TBL] [Abstract][Full Text] [Related]
20. [Pellet technology. Sustained-release pellets in hard gelatin capsules--a suitable dosage form for theophylline]. Laicher A; Fuchs WS Arzneimittelforschung; 1998 May; 48(5A):540-7. PubMed ID: 9676341 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]